Transmission of ESBL-producing Enterobacteriaceae
ConditionHospital Acquired Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
The aim of this research project is to investigate the transmission of ESBL-producing Enterobacteriaceae on both, the level of bacterial strains and mobile genetic elements, and to determine the source of hospital-acquired infections.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
aged above 1 year
proven ESBL-PE carriage from any specimens obtained by routine clinical practice out and inpatients from University Hospital Basle from January 1st until December 31st 2019
Disqualifiers
not meeting inclusion criteria
Trial population
out and inpatients from University Hospital Basle
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
ESBL-producing Enterobacteriaceae
Other interventionData and biological sample collection
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Infection/colonization proportion
The proportion of infection/colonization with genetically related isolates of ESBL-producing Enterobacteriaceae (primary outcome) of the overall infection/colonization rate will be determined and stratified for both, in and outpatient setting for species and time periods
Time frame
through study completion, an average of 45monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov